Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.04 CHF | -1.44% | -0.88% | -1.12% |
09/01 | Unilever's Indonesia headache worsens with boycott as local brands seize the day | RE |
08/01 | NESTLE : Bernstein sticks Neutral | ZD |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 9.26TCr | 8.43TCr | 8.71TCr | 9.44TCr | 9.3TCr | |||||
Other Revenues, Total | 30Cr | 34Cr | 38Cr | 36Cr | 35Cr | |||||
Total Revenues | 9.29TCr | 8.47TCr | 8.75TCr | 9.48TCr | 9.34TCr | |||||
Cost of Goods Sold, Total | 4.66TCr | 4.28TCr | 4.55TCr | 5.17TCr | 5.03TCr | |||||
Gross Profit | 4.62TCr | 4.18TCr | 4.2TCr | 4.3TCr | 4.3TCr | |||||
Selling General & Admin Expenses, Total | 2.84TCr | 2.52TCr | 2.53TCr | 2.53TCr | 2.54TCr | |||||
R&D Expenses | 167.2Cr | 157.6Cr | 167Cr | 169.6Cr | 165.6Cr | |||||
Other Operating Expenses | 21Cr | 50Cr | 38Cr | 29Cr | 34Cr | |||||
Other Operating Expenses, Total | 3.03TCr | 2.73TCr | 2.74TCr | 2.73TCr | 2.74TCr | |||||
Operating Income | 1.59TCr | 1.45TCr | 1.46TCr | 1.58TCr | 1.57TCr | |||||
Interest Expense, Total | -102.6Cr | -83Cr | -82Cr | -112.4Cr | -150Cr | |||||
Interest And Investment Income | 16Cr | 7.7Cr | 4.2Cr | 14Cr | 19Cr | |||||
Net Interest Expenses | -86Cr | -75Cr | -77Cr | -98Cr | -130.8Cr | |||||
Income (Loss) On Equity Invest. | 100.1Cr | 181.5Cr | 865.1Cr | 104Cr | 112Cr | |||||
Other Non Operating Income (Expenses) | -20L | 30L | -20L | -10L | -10L | |||||
EBT, Excl. Unusual Items | 1.6TCr | 1.56TCr | 2.25TCr | 1.58TCr | 1.55TCr | |||||
Restructuring Charges | -55Cr | -22Cr | -31Cr | -27Cr | -72Cr | |||||
Merger & Related Restructuring Charges | -1.1Cr | -4.5Cr | -5.5Cr | -4.6Cr | -2.7Cr | |||||
Impairment of Goodwill | -78Cr | -40Cr | -35Cr | -7.1Cr | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 341.4Cr | 176.3Cr | 32Cr | -6.8Cr | -23Cr | |||||
Asset Writedown | -155.7Cr | -31Cr | -226.1Cr | -276.1Cr | -65Cr | |||||
Legal Settlements | -48Cr | -24Cr | -56Cr | -40Cr | -17Cr | |||||
Other Unusual Items | - | -42Cr | 16Cr | 14Cr | 16Cr | |||||
EBT, Incl. Unusual Items | 1.61TCr | 1.57TCr | 1.95TCr | 1.23TCr | 1.38TCr | |||||
Income Tax Expense | 315.9Cr | 336.5Cr | 226.1Cr | 273Cr | 231.4Cr | |||||
Earnings From Continuing Operations | 1.29TCr | 1.24TCr | 1.72TCr | 959.6Cr | 1.15TCr | |||||
Net Income to Company | 1.29TCr | 1.24TCr | 1.72TCr | 959.6Cr | 1.15TCr | |||||
Minority Interest | -30Cr | -14Cr | -29Cr | -33Cr | -30Cr | |||||
Net Income - (IS) | 1.26TCr | 1.22TCr | 1.69TCr | 927Cr | 1.12TCr | |||||
Net Income to Common Incl Extra Items | 1.26TCr | 1.22TCr | 1.69TCr | 927Cr | 1.12TCr | |||||
Net Income to Common Excl. Extra Items | 1.26TCr | 1.22TCr | 1.69TCr | 927Cr | 1.12TCr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.3 | 4.3 | 6.06 | 3.42 | 4.24 | |||||
Basic EPS - Continuing Operations | 4.3 | 4.3 | 6.06 | 3.42 | 4.24 | |||||
Basic Weighted Average Shares Outstanding | 292.9Cr | 284.5Cr | 278.8Cr | 270.7Cr | 264.6Cr | |||||
Net EPS - Diluted | 4.3 | 4.29 | 6.06 | 3.42 | 4.23 | |||||
Diluted EPS - Continuing Operations | 4.3 | 4.29 | 6.06 | 3.42 | 4.23 | |||||
Diluted Weighted Average Shares Outstanding | 293.4Cr | 284.9Cr | 279.1Cr | 270.9Cr | 264.8Cr | |||||
Normalized Basic EPS | 3.32 | 3.38 | 4.94 | 3.53 | 3.54 | |||||
Normalized Diluted EPS | 3.31 | 3.38 | 4.94 | 3.53 | 3.54 | |||||
Dividend Per Share | 2.7 | 2.75 | 2.8 | 2.95 | 3 | |||||
Payout Ratio | 57.34 | 62.95 | 45.44 | 82.18 | 69.85 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.87TCr | 1.71TCr | 1.71TCr | 1.83TCr | 1.82TCr | |||||
EBITA | 1.59TCr | 1.46TCr | 1.48TCr | 1.59TCr | 1.58TCr | |||||
EBIT | 1.59TCr | 1.45TCr | 1.46TCr | 1.58TCr | 1.57TCr | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 19.67 | 21.38 | 11.62 | 22.15 | 16.74 | |||||
Total Current Taxes | 308.4Cr | 281.4Cr | 261.6Cr | 256.6Cr | 289.1Cr | |||||
Total Deferred Taxes | -3.5Cr | 66Cr | 35Cr | 4.8Cr | -78Cr | |||||
Normalized Net Income | 972.5Cr | 961.56Cr | 1.38TCr | 955.46Cr | 936.81Cr | |||||
Interest on Long-Term Debt | 9.8Cr | 7.9Cr | 6.6Cr | 7.2Cr | 8.6Cr | |||||
Non-Cash Pension Expense | -5.6Cr | 6.7Cr | 5.2Cr | 90L | -30L | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 849.6Cr | 785.1Cr | 791.9Cr | 838.6Cr | 776.5Cr | |||||
Research And Development Expense From Footnotes | 167.2Cr | 157.6Cr | 167Cr | 169.6Cr | 165.6Cr | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 31Cr | 27Cr | 24Cr | 18Cr | 21Cr | |||||
Total Stock-Based Compensation | 31Cr | 27Cr | 24Cr | 18Cr | 21Cr |